# Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection

> **NCT05082441** · PHASE4 · UNKNOWN · sponsor: **Samaritan Health Services** · enrollment: 140 (estimated)

## Conditions studied

- Benign Neoplasm

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT05082441
- **Lead sponsor:** Samaritan Health Services
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082441, "Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05082441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*